ET-01 in Subjects With Lateral Canthal Lines, LCL-207
Public ClinicalTrials.gov record NCT03655691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Trial to Evaluate ET-01 in Subjects With Lateral Canthal Lines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Study identification
- NCT ID
- NCT03655691
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 25 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2018
- Primary completion
- Nov 8, 2018
- Completion
- Apr 10, 2019
- Last update posted
- Apr 20, 2022
2018 – 2019
United States locations
- U.S. sites
- 6
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Baumann Cosmetic & Research Institute | Miami | Florida | 33137 | — |
| Radiant Research, Inc. | Pinellas Park | Florida | 33781 | — |
| Research Institute of the Southeast, LLC | West Palm Beach | Florida | 33401 | — |
| Dermatology NOLA Inc. | Metairie | Louisiana | 70006 | — |
| Westlake Dermatology Clinical Research Center | Austin | Texas | 78746 | — |
| Virginia Clinical Research, Inc. | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03655691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 20, 2022 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03655691 live on ClinicalTrials.gov.